back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-04 14:31 Tx date 2025-07-02 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+4,000,000 vol |
4,000,000 | |
| Filed 2025-03-20 18:04 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$37,333
+177,777 vol $0.21 each |
893,332 | |
| Filed 2025-03-20 18:03 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
38 - Redemption, retraction, cancellation, repurchase
|
-1 vol |
0 | |
| Filed 2025-03-20 18:03 Tx date 2025-03-18 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,777 vol |
1 | |
| Filed 2024-09-23 13:53 Tx date 2024-09-20 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$42,666
+177,778 vol $0.24 each |
715,555 | |
| Filed 2024-09-23 13:52 Tx date 2024-09-20 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,778 vol |
177,778 | |
| Filed 2024-09-23 09:55 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,778 vol |
||
| Filed 2024-09-23 09:55 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$42,666
+177,778 vol $0.24 each |
||
| Filed 2024-09-20 19:58 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$42,666
+177,778 vol $0.24 each |
||
| Filed 2024-09-20 19:57 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,778 vol |
||
| Filed 2024-09-20 19:58 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$42,666
+177,778 vol $0.24 each |
715,555 | |
| Filed 2024-09-20 19:57 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,778 vol |
177,778 | |
| Filed 2024-09-20 19:57 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,778 vol |
||
| Filed 2024-09-20 19:56 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,778 vol |
||
| Filed 2024-09-20 19:55 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,778 vol |
||
| Filed 2024-09-20 19:53 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-177,778 vol |
||
| Filed 2024-03-28 10:19 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-360,000 vol |
355,556 | |
| Filed 2024-03-28 10:19 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+360,000 vol |
537,777 | |
| Filed 2024-03-28 10:18 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+177,777 vol |
177,777 | |
| Filed 2024-03-28 10:17 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Flom, Eyal
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|